1,608 research outputs found
μν λ΄ λ³μμ± λμ₯κ· O157:H7μ κ²μΆμ μν μνλ¨Έ κΈ°λ°μ μ΄μ€κΈ°λ₯λ§μ»€ κ°λ° λ° κΈ λλ Έμ μ μμ§ κΈ°λ° λΉμ μ΄μΈμ΄ κ°λ°
νμλ
Όλ¬Έ(μμ¬) -- μμΈλνκ΅λνμ : λμ
μλͺ
κ³Όνλν λμλͺ
곡νλΆ, 2023. 2. μ΅μμ§.In this study, we developed a colorimetric assay with bi-functional gold nanoparticle (AuNP) based on aptamer for sensitive detection of Escherichia coli O157:H7 using the aggregation of AuNP linked with a complementary DNA aptamer specific to E. coli O157:H7 aptamer. AuNP was used as a colorimetric linker and probe, respectively, and E. coli O157:H7 aptamer and its complementary DNA sequences were modified on each AuNP surface. AuNP labeled with E. coli O157:H7 aptamer was used as a bi-functional linker (BL) in a colorimetric competitive assay. Colorimetric assay with BL based on aptamer detected target bacteria by sequential competitive binding between colorimetric probes, which are AuNP having complementary sequences of E. coli O157:H7 (AA, Aggregation Assistant) and E. coli O157:H7 aptamer. In addition, under optimized conditions by main testing parameters, the assay exhibited a detection range of 101 to 106 CFU/400 Β΅L and a detection limit of 57 Β± 0.5 CFU/400 Β΅L. In addition, the developed colorimetric assay with BL based on aptamer was excellently evaluated as an on/off detection system in coconut water, a real matrix. Thus, the proposed colorimetric competitive assay with BL based on aptamer can be a proper on-site detection method of foodborne pathogens. In addition, this study provides the basis for research into developing different colorimetric assay with aptamer for pathogen analysis in real matrices.
This colorimetric assay with BL based on aptamer functions by driving the system between two competitive interaction dynamics: A) affinity between the aptamer sequence and the target, and B) affinity between the aptamer and the its complementary DNA aptamer.μ΄ μ°κ΅¬μμ μ°λ¦¬λ E. coli O157μ νΉμ΄μ μΈ μνλ¨Έμ μ보μ DNA μνλ¨Έκ° κ²°ν©λ AuNPμ μμ§μ κΈ°μ΄νμ¬ E. coli O157:H7μ νμ₯μμ μ μνλ©° λ―Όκ°νκ² κ²μΆν μ μλ, μνλ¨Έκ° κ²°ν©λ μ΄μ€ κΈ°λ₯λ§μ»€ AuNPλ₯Ό μ΄μ©ν λΉμ κ²μΆλ²μ κ°λ°νμλ€. μ΄ μμ€ν
μμ AuNPλ μ΄μ€κΈ°λ₯λ§μ»€ λ° μμ§λ³΄μ‘° νλ‘λΈλ‘ μ¬μ©λμμΌλ©°, κ° AuNP νλ©΄μ E. coli O157:H7 λμ μνλ¨Έμ μ보μ μΈ DNA μμ΄μ μνλ¨Έλ‘ κ²°ν©λμμΌλ©°, μ΄λ κ°κ° μ΄μ€κΈ°λ₯λ§μ»€ AuNP (BL)μ μμ§λ³΄μ‘° νλ‘λΈ AuNP (AA)λ‘ λͺ
λͺ
νμλ€. BLμ λμκ· μ΄ μ‘΄μ¬νμ§ μμ λμλ μ보μ μΈ μμ΄μ μν΄ AAμ κ²°ν©νμμΌλ©°, μμ κ· νμ μν΄ νΉμ μμ(REVC, 120 β 220 ΞΌL)μμ μμ§ λ° μΉ¨μ μ΄ μΌμ΄λ¬λ€. νμ§λ§, λμκ· μ΄ ν¬μ
λμμ λμλ κ²½μμ κ²°ν© μ°μ μμμ μν΄ μ보μ μμ΄μ AAκ° μλλΌ λμκ· μΈ E. coli O157:H7κ³Ό κ²°ν©νκ² λλ€. μ΄λ κΈ°μ‘΄μ μμ κ· νμμμ μ°¨μ΄λ₯Ό μΌμΌν€κ² λκ³ λμ‘°κ΅°κ³Ό μ μ¬ν μμ§ λ° μΉ¨μ μ΄ μΌμ΄λκΈ° μν΄μλ κΈ°μ‘΄λ³΄λ€ λ λ§μ μμ BLμ΄ λ°μμ μ°Έμ¬νμ¬μΌ νλ€. μ΄λ₯Ό ν΅ν΄ λμ‘°κ΅°κ³Ό λμκ· κ°μλ REVC μμμ λ³νκ° λ°μνκ² λλ©°, μ΄λ₯Ό ν΅ν΄ λμκ· μ μ 무λ₯Ό νμΈν μ μμλ€. κ²μΆμ κ°μ₯ λ―Όκ°νλ©° ꡬλΆλλ BL μμμΈ 100, 120, 140 ΞΌLμμ μ§νλμμΌλ©°, μ΅μ νλ 쑰건μμ 101 ~ 106 CFU/400 ΞΌLμ κ²μΆ λ²μμ 57 Β± 0.5 CFU/400 Lμ κ²μΆ νκ³λ₯Ό λνλλ€. λν μνλ¨Έ κΈ°λ°μ BLμ μ΄μ©ν λΉμλΆμλ²μ μ€μ 맀νΈλ¦μ€μΈ μ½μ½λμν°μμλ on/off κ°μ§ μμ€ν
μΌλ‘ λ§€μ° μ°μνκ² νκ°λμλ€. λ°λΌμ μ μλ μνλ¨Έ κΈ°λ°μ BLμ μ΄μ©ν λΉμλΆμλ²μ μμ€λ
μ μΌμΌν€λ λ³μ체λ₯Ό νμ₯μμ κ²μΆνλ λ° μ ν©ν λ°©λ²μ΄ λ μ μμ κ²μΌλ‘ κΈ°λλλ€. λν, λ³Έ μ°κ΅¬λ₯Ό ν΅ν΄ μ€μ 맀νΈλ¦μ€μμ λ³μκ· λΆμμ μν μ±νλ¨Έ κΈ°λ° λΉμ λΆμ κ°λ°μ λν ν₯ν μ°κ΅¬μ κΈ°λ°μ μ 곡ν μ μμλ€. μ΄ μνλ¨Έ κΈ°λ° λΉμ λΆμλ²μ A) μνλ¨Έ μμ΄κ³Ό νμ μ¬μ΄μ μΉνμ±, B) μνλ¨Έμ κ·Έ μ보μ μΈ DNA μνλ¨Έ μ¬μ΄μ μΉνλ ₯μ΄λΌλ λ κ°μ§ κ²½μμ μΈ μνΈ μμ© μνμ μν΄ κ΅¬λλμλ€.β
. INTRODUCTION οΌ
β
‘. MATERIALS AND METHODS 5
2.1. Materials 5
2.2. Instrumentation 5
2.3. Culturing of Bacteria 6
2.4. Preparation of gold nanoparticles (AuNP) 6
2.5. Modification of AuNP with aptamer 7
2.6. Optimization of NaCl concentrations 8
2.7. Detection of E. coli O157:H7 in samples 8
2.8. Verification of the selectivity of the detection method 9
2.9. Statistical analysis 10
β
’. RESULTS AND DISCUSSION 11
3.1. Overall detection procedures 11
3.2. Optimization of NaCl concentrations 17
3.3. Selectivity of the colorimetric assay 25
3.4. The range of REVC 27
3.5. Detection of E. coli O157:H7 in HEPES buffer 29
3.6. Detection of E. coli O157:H7 in coconut water 34
CONCLUSION 39
REFERENCES 41
κ΅λ¬Έμ΄λ‘ 45μ
Is the Direct Fixation of Displaced Quadrilateral Plates in Acetabular Fractures Necessary?
Quadrilateral plate fractures represent a heterogeneous group of acetabular fractures. Accurate reduction is required to prevent post-traumatic arthritis. The purpose of this study is to determine the reduction effect of the direct fixation of quadrilateral plates in acetabular fractures, and to evaluate the strength of direct fixation compared to indirect fixation. Between 2005 and 2021, 49 patients underwent surgery for open reduction and internal fixation in acetabular fractures with severely displaced quadrilateral plates. Twenty-nine patients comprised the indirect fixation group, and twenty patients comprised the direct fixation group. In a comparison of primary outcome between two groups, 10 out of 29 indirect-group patients and 1 out of 20 direct-group patients developed post-traumatic osteoarthritis, wherein the difference between the two groups is statistically significant. In the assessment of postoperative Matta\u27s radiological reduction status, 19 out of 20 patients in the direct group had achieved anatomical and congruent reduction. The treatment using a direct reduction and internal fixation improved the reduction quality of articular displacement and offered a better survivorship of the affected hip joint
Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome
PurposeTo investigate the efficacy of topiramate monotherapy in West syndrome prospectively.MethodsThe study population included 28 patients (15 male and 13 female children aged 2 to 18 months) diagnosed with West syndrome. After a 2-week baseline period for documentation of the frequency of spasms, topiramate was initiated at 2 mg/kg/day. The dose was increased by 2 mg/kg every week to a maximum of 12 mg/kg/day. Clinical assessment was based on the parents' report and a neurological examination every 2 weeks for the first 2 months of treatment. The baseline electroencephalograms (EEGs) were compared with the post-treatment EEGs at 2 weeks and 1 month.ResultsWest syndrome was considered to be cryptogenic in 7 of the 28 patients and symptomatic in 21 patients. After treatment, 11 patients (39%) became spasm-free, 6 (21%) had more than 50% spasmsreduction, 3 (11%) showed less than 50% reduction, and 8 (29%) did not respond. The effective daily dose for achieving more than 50% reduction in spasm frequency, including becoming spasm-free, was found to be 5.8Β±1.1 mg/kg/day. Nine patients (32%) showed complete disappearance of spasms and hypsarrhythmia, and 11 (39%) showed improved EEG results. Despite adverse events (4 instances of irritability, 3 of drowsiness, and 1 of decreased feeding), no patients discontinued the medication.ConclusionTopiramate monotherapy seems to be effective and well tolerated as a first line therapy for West syndrome and is not associated with serious adverse effects
Determining the Optimal Dosage of Dexmedetomidine for Smooth Emergence in Older Patients Undergoing Spinal Surgery: A Study of 44 Cases
BACKGROUND Emergence agitation, or delirium, occurs during early recovery from general anesthesia and involves disorientation, excitation, and uncontrolled physical movements. Dexmedetomidine is an alpha agonist that has sedative, anxiolytic, analgesic, and sympatholytic activities and is used as a continuous infusion to prevent emergence agitation. This study aimed to evaluate patients aged 65 years and older undergoing general anesthesia to determine the 90% effective dose (ED90) of dexmedetomidine continuous intraoperative infusion to prevent emergence agitation. MATERIAL AND METHODS We enrolled 44 patients aged 65 years and older undergoing spinal surgery under general anesthesia. Dexmedetomidine administration commenced 30 minutes before surgery completion, with a predetermined infusion dose (ΞΌg/kg/h), without a loading dose. The initial dose was 0.2 ΞΌg/kg/h, and subsequent step size was Β±0.05 ΞΌg/kg/h. We tried to find ED90 of dexmedetomidine using the biased-coin design. Vital signs, extubation quality scores, extubation-related complications, and postoperative outcomes were monitored. RESULTS Dexmedetomidine EDββ for smooth emergence in older patients was 0.34 ΞΌg/kg/h. Peri-extubation vital signs remained within 20% of baseline values, without requiring pharmacological intervention. No hypoxia, hypoventilation, or post-extubation agitation occurred. In the recovery room, 1 patient briefly exhibited excitement but quickly calmed. Nine patients initially unresponsive in the recovery room fully awoke and were promptly discharged. CONCLUSIONS For older patients who are vulnerable to adverse effects of anesthetics and opioids, dexmedetomidine enables gentle awakening without adverse vital sign changes, respiratory depression, excessive sedation, or emergence agitation (EDββ=0.34 ΞΌg/kg/h). Further studies should involve a larger patient cohort, considering diverse medical conditions in older individuals
Association Between Obstructive Sleep Apnea and Risk of Benign Vocal Fold Lesions: A Nationwide 9-Year Follow-Up Cohort Study
Since obstructive sleep apnea (OSA) affects various parts of the body, there has been little interest about the effect of OSA on voice. The objective of this study was to evaluate the risk of benign vocal fold lesions (BVFL) in OSA patients. This study used data from the National Health Insurance Service (NHIS) database. The study group was defined as the group diagnosed with OSA between 2008 and 2011. Non-OSA groups were selected based on propensity score (PS) matching. Incidence of BVFL among participants during the follow-up was analyzed. Cox proportional hazard regression analyses were performed to evaluate the association between OSA and incident BVFL. The HR value of the OSA group calculated by considering 8 variables indicates that the risk of developing BVFL is 79% higher than that of the control group. Further, among OSA patients, patients with a history of OP had a 35% lower risk of developing BVFL. The relationships between BVFL and 7 individual variables considered were as follows: For age, HR for the 40 to 59 years group was 1.20 (95%CI, 1.09-1.32). For sex, the HR in the female group was 1.22 (95%CI, 1.10-1.35). For residential areas, the HR values for Seoul 1.39 (95%CI, 1.23-1.59). In the high economic status group, the HR was 1.10 (95%CI, 1.01-1.21). This observational study indicated that OSA is associated with an increased incidence of BVFL. The incidence of BVFL increased with older age, female sex, and high SES
- β¦